The crude alkaloidal extract of Picralima nitida seeds alleviates TNBS-induced inflammatory bowel disease through reduced serum expression of TNF-α, IL-1β and p38 MAPK

No abstract is available for this paper.

• Publication year

  2024

• Venue

  Nutrire

• Publication date

  2024-12-30

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1186/s41110-024-00309-z
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Acetic acid‐induced colitis modulating potential of total crude alkaloidal extract of Picralima nitida seeds in rats

  2023cited by this paper
• Anti-Inflammatory Activity of the Stem Bark Methanol Extract of Picralima nitida

  2021cited by this paper
• Ulcerative colitis induced with acetic acid is ameliorated by Antrocaryon micraster through reduced serum levels of tumor necrosis factor alpha and interleukin-6 in sprague dawley rats

  2020cited by this paper
• Aqueous extract of dry powder blend of seeds and leaves of Picralima nitida (Stapf) T. & H. Durand reduce pain and inflammation in animal models

  2020cited by this paper
• Potential effects of xylopic acid on acetic acid-induced ulcerative colitis in rats.

  2019cited by this paper
• Preclinical Study in Vivo for New Pharmacological Approaches in Inflammatory Bowel Disease: A Systematic Review of Chronic Model of TNBS-Induced Colitis

  2019cited by this paper
• Anti-inflammatory effect of Chang-An-Shuan on TNBS-induced experimental colitis in rats

  2017cited by this paper
• The TNBS-induced colitis animal model: An overview

  2016cited by this paper
• The fruit extract of Xylopia aethiopica (dunal) a. rich. (annonaceae) and its principal constituent, Xylopic acid, modulate inflammation

  2015cited by this paper
• Medicinal uses, phytochemistry and pharmacology of Picralima nitida (Apocynaceae) in tropical diseases: a review.

  2014cited by this paper
• Picralima nitida seeds suppress PGE2 production by interfering with multiple signalling pathways in IL-1β-stimulated SK-N-SH neuronal cells.

  2014cited by this paper
• Anti-inflammatory and anti-oxidant activities of olmesartan medoxomil ameliorate experimental colitis in rats.

  2013cited by this paper
• Abstract 1515: Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer.

  2013cited by this paper
• Natural Products as a Source of Anti-Inflammatory Agents Associated with Inflammatory Bowel Disease

  2013cited by this paper
• Anti-inflammatory effects of Retama monosperma in acute ulcerative colitis in rats

  2013cited by this paper
• Mechanisms of Motility Change on Trinitrobenzenesulfonic Acid-Induced Colonic Inflammation in Mice

  2012cited by this paper
• Pretreatment with Interferon‐γ Enhances the Therapeutic Activity of Mesenchymal Stromal Cells in Animal Models of Colitis

  2011cited by this paper
• Protective Effects of Black Cumin (Nigella sativa) Oil on TNBS-Induced Experimental Colitis in Rats

  2011cited by this paper
• Anti-inflammatory effects of methanol extract of Patrinia scabiosaefolia in mice with ulcerative colitis.

  2011cited by this paper
• Anti‐inflammatory potential of Phaseolus calcaratus Roxburgh, a oriental medicine, on LPS‐stimulated RAW 264.7 macrophages

  2011influential reference
• New Horizons in Management of Inflammatory Bowel Disease

  2011cited by this paper
• Mechanisms by which inflammation may increase intestinal cancer risk in inflammatory bowel disease

  2010cited by this paper
• Anti-inflammatory intestinal activity of Abarema cochliacarpos (Gomes) Barneby & Grimes in TNBS colitis model.

  2010cited by this paper
• Vitisin A suppresses LPS-induced NO production by inhibiting ERK, p38, and NF-kappaB activation in RAW 264.7 cells.

  2009influential reference
• Inhibition of Tumor Necrosis Factor and Nitrosative/Oxidative Stresses by Ziziphora Clinopoides (Kahlioti); A Molecular Mechanism of Protection Against Dextran Sodium Sulfate-Induced Colitis in Mice

  2009cited by this paper
• Simvastatin Attenuates Trinitrobenzene Sulfonic Acid-Induced Colitis, but Not Oxazalone-Induced Colitis

  2008cited by this paper
• Ameliorative effect of pyrrolidinedithiocarbamate on acetic acid-induced colitis in rats.

  2007cited by this paper
• Inflammatory bowel disease: cause and immunobiology

  2007cited by this paper
• Fecal levels of leukocyte markers reflect disease activity in patients with ulcerative colitis

  2007cited by this paper
• [Effects of ERK5 MAPK signaling transduction pathway on the inhibition of genistein to breast cancer cells].

  2006cited by this paper
• Protective effect of Cissus quadrangularis on neutrophil mediated tissue injury induced by aspirin in rats.

  2006cited by this paper
• Levels of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase are reduced in inflammatory bowel disease: evidence for involvement of TNF-alpha.

  2006cited by this paper
• Inflammatory bowel disease: Epidemiology, pathogenesis, and therapeutic opportunities

  2006cited by this paper
• Total alkaloidal extract of picralima nitida (fam. apocynaceae) seeds has anti-inflammatory actions

  2006influential reference
• Preventative Effects of Lactulose in the Trinitrobenzenesulphonic Acid Model of Rat Colitis

  2005cited by this paper
• Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics.

  2004cited by this paper
• Publisher's Note

  2003cited by this paper
• Amelioration of TNBS-induced colon inflammation in rats by phospholipase A2 inhibitor.

  2003cited by this paper
• Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn's disease.

  2002cited by this paper
• Pseudo-akuammigine, an alkaloid from Picralima nitida seeds, has anti-inflammatory and analgesic actions in rats.

  2002cited by this paper
• The current future understanding of inflammatory bowel disease.

  2002cited by this paper
• Pharmacotherapeutic options in inflammatory bowel disease: an update.

  2001cited by this paper
• Relation Between Colonic Inflammation Severity and Total Low-Molecular-Weight Antioxidant Profiles in Experimental Colitis

  2000cited by this paper
• Cyclooxygenase-2-dependent arachidonic acid metabolites are essential modulators of the intestinal immune response to dietary antigen

  1999cited by this paper
• The AgNOR count in ulcerative colitis with and without dysplasia

  1997cited by this paper
• Antibodies to interleukin 12 abrogate established experimental colitis in mice

  1995cited by this paper
• Reactivation of hapten-induced colitis and its prevention by anti-inflammatory drugs.

  1995cited by this paper
• Depleted mucosal antioxidant defences in inflammatory bowel disease.

  1995cited by this paper
• Experimental models of inflammatory bowel disease.

  1995cited by this paper
• The effect of anti‐inflammatory drugs on eicosanoid formation in a chronic model of inflammatory bowel disease in the rat

  1988cited by this paper
• Photoperoxidation in isolated chloroplasts. I. Kinetics and stoichiometry of fatty acid peroxidation.

  1968cited by this paper
• Preparation and characterization of antibodies specific for the 2,4,6-trinitrophenyl group.

  1966cited by this paper

• Comprehensive pharmacokinetics and ADME evaluation of Akuamma alkaloids.

  2025cites this paper
• A precision-engineered chitosan alleviates gastric ulcers and restores gut microbiota homeostasis in rats: Dual mechanisms of mucosal barrier fortification and oxidative stress mitigation.

  2025cites this paper